Your browser doesn't support javascript.
loading
Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study.
Li, Zhenhui; Zhu, Haibin; Pang, Xiaolin; Mao, Yun; Yi, Xiaoping; Li, Chunxia; Lei, Ming; Cheng, Xianshuo; Liang, Lei; Wu, Jiamei; Ding, Yingying; Yang, Jun; Sun, Yingshi; Zhang, Tao; You, Dingyun; Liu, Zaiyi.
Afiliación
  • Li Z; Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.
  • Zhu H; Guangdong Cardiovascular Institute, Guangzhou, 510080, China.
  • Pang X; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.
  • Mao Y; Department of Radiology, Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming, 650118, China.
  • Yi X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Li C; Department of Radiotherapy, Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510655, China.
  • Lei M; Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
  • Cheng X; Department of Radiology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Liang L; Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Wu J; Department of Clinical Laboratory Medicine, Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming, 650118, China.
  • Ding Y; Department of Colorectal Surgery, Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming, 650118, China.
  • Yang J; Department of Oncology, the First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China.
  • Sun Y; Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
  • Zhang T; Department of Radiology, Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming, 650118, China.
  • You D; Department of Oncology, the First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China. yangjun6@kmmu.edu.cn.
  • Liu Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, 100142, China. sys27@163.com.
BMC Cancer ; 22(1): 962, 2022 Sep 08.
Article en En | MEDLINE | ID: mdl-36076189
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Antígeno CA-19-9 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Antígeno CA-19-9 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China